Riskpilot← Back to searchSign inGet full accessGlobal Medi-Point Oy
OYDissolvedY-tunnus 2692382-3Kaunispääntie 2-M96Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2015— employeeswww.medipoint.fi
Revenue 2025
EUR 12K
-28% vs 2024
EBITDA margin
42.1%
+636% vs 2024
Equity ratio
92.5%
Financial strength
Net profit 2025
EUR 5K
+649% vs 2024
| Revenue | EUR 12K | -28% |
| EBITDA | EUR 5K | +636% |
| Net profit | EUR 5K | +649% |
| Total assets | EUR 40K | -19% |
| Equity | EUR 37K | -20% |
| Employees | — | — |
Legal name
Global Medi-Point Oy
Y-tunnus number
2692382-3
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. toukokuuta 2015
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on sairaala- hammaslääkäri- elintarvike- ja kauneudenhoitoalan tarvikkeiden ja välineiden maahantuonti ja vienti sekä kaikki muu laillinen liiketoiminta. Yhtiö voi omistaa ja hallita kiinteistöjä, asunto-osakkeita, arvopapereita, rakennuksia ja kiinteää omaisuutta sekä käydä niillä kauppaa.
Address
Kaunispääntie 2-M96
Email
global.medipoint@gmail.com
Website
www.medipoint.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 30 | 0 | 0 | 17 | 12 |
| Staff expenses | −14 | −12 | −0 | −10 | −0 |
| EBITDA | 2 | 0 | 0 | 1 | 5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 | 8 | 0 | 1 | 5 |
| Net financials | −1 | 0 | 0 | 1 | 1 |
| Profit before tax | 1 | 0 | 0 | 1 | 6 |
| Tax | 0 | −0 | −0 | 1 | 0 |
| Net profit | 1 | 9 | 0 | 1 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 124 | 103 | 58 | 50 | 40 |
| Equity | 48 | 53 | 50 | 47 | 37 |
| Long-term debt | 67 | 2 | 1 | 0 | 0 |
| Short-term debt | 9 | 17 | 7 | 3 | 3 |
| Total debt | 76 | 18 | 8 | 3 | 3 |
EBITDA margin
42.1%
This company
15.8%
Market median
+166% vs market
20212025
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
20212025
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20212025
Net profit margin
45.6%
This company
8.1%
Market median
+463% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LK Deputy Member | Deputy Member | 2022 |
EM Chief Executive Officer | Chief Executive Officer | 2015 |
| Former (2) | ||
FH Deputy Member | Deputy Member | 2019 – 2022 |
IJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2015 – 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Global Medi-Point Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Faina Helena Kanerva | Deputy Member | 0 companies |
| Linnea Katariina Laitinen | Deputy Member | 0 companies |
| Ilpo Juhani Myllymäki | Deputy Chief Executive Officer | 0 companies |
| Elina Miriam Myllymäki | Chief Executive Officer | 0 companies |